Bir Ergen Olguda Sertralin Kullanımı ile İlişkili Servikal Distoni

Son yıllarda selektif serotonin geri alım inhibitörleri (SSGI) yan etkilerinin az olması nedeniyle çocuk ve ergen psikiyatrisi pratiğinde sıkça kullanılmaktadırlar. Bu güvenirliklerine rağmen, SSGI kullanımına bağlı ekstrapiramidal sistem bulguları olarak; akatizi, distoni, parkinsonizm, tremor ve geç diskinezi bildirilen vakalar literatürde bulunmaktadır. Bu yazıda sertralin tedavisi ile servikal distoni oluşumu gözlenen bir ergen olgu tartışılmış- tır. Bilebildiğimiz kadarıyla olgumuz, ergenlik yaş döneminde sertralin kullanımı sonucu oluşan ikinci distoni olgusudur

Cervical Dystonia Associated with Sertraline in an Adolescent A Case

In recent years, selective serotonin reuptake inhibitors (SSRI) are widely prescribed in child and adolescent psychiatry practice because they are regarded as having less severe side-effects. Despite reliabilities, acathisia, dystonia, parkinsonism, tremor and tardive dyskinesia have been reported as the extrapyramidal system findings associated with use of SSRIs. In this report, we discuss a clinical case of cervical dystonia secondary to sertraline use in an adolescent patient. To the best of our knowledge, this is the second case of dystonia associated with sertraline use in an adolescent patient.

PDF

___

1. Chan J, Brin MF, Fahn S. Idiopathic cervical dystonia: clinical characteristics. Mov Disord 1991; 6: 119-26.
2. Lowenstein DH, Aminoff MJ. The clinical course of spasmodic torticollis. Neurol 1988; 38: 530-32.
3. Fahn S, Marsden CD, Calne DB. Classification and investigation of dystonia. In: Marsden CD, Fahn S (editors). Movement disorders. second ed., London: Butteworths, 1987: 332-58.
4. Gerber PE, Lynd LD. Selective serotonin-reuptake inhibitorinduced movement disorders. Ann Pharmacother 1998; 32: 692- 98.
5. Leo RJ. Movement disorders associated with the serotonin selective reuptake inhibitors. J Clin Psychiatry 1996; 57: 449-54.
6. Stanislav SW, Childs NL. Dystonia associated with sertraline. J Clin Psychopharmacol 1999; 19: 98-100.
7. Bilen S, Saka M, Ak F, Oztekin N. Persistent dystonia induced by fluoxetine. Intern Med J 2008; 38: 672-74.
8. Annagür BB, Tamam L. Fluvoksamin kullanımı sırasında ortaya çıkan distoni: bir olgu. Klinik Psikiyatri 2009; 12: 197-200.
9. Madhusoodanan S, Alexeenko L, Sanders R, Brenner R. Extrapyramidal symptoms associated with antidepressants. A review of the literature and analysis of spontaneous reports. Ann Clin Psychiatry 2010; 22: 148-56.
10. Walker L. Sertraline-induced akathisia and dystonia misinterpreted as a panic attack (letter). Psychiatric Services 2002; 53: 1477-78.
11. Muthusami S, Basu S, Kumar A, Dash A. Acute dyskinesia and extrapyramidal disorder in a child after ingestion of escitalopram. J Child Adolesc Psychopharmacol 2009; 19: 317-18.
12. Parvin MM, Swartz CM. Dystonic rabbit syndrome from citalopram. Clin Neuropharmacol 2005; 28: 289-91.
13. Diler RS, Yolga AY, Avci A. Fluoxetine-induced extrapyramidal symptoms in an adolescent: a case report. Swiss Med Wkly 2002; 132: 125-6.
14. Wils V. Extrapyramidal symptoms in a patient treated with fluvoxamine. J Neurol Neurosurg Psychiatry 1992; 55: 330-31.
15. Shihabuddin L, Rapport D. Sertraline and extrapyramidal side effects. Am J Psychiatry 1994; 151: 288.
16. Kölling P, Jansen Steur EN, de Burlet HM. Extrapyramidal disorders following sertraline use; experiences with a new selective antidepressant. Ned Tijdschr Geneeskd 1996; 140: 1467-68.
17. Madhusoodanan S, Brenner R. Reversible choreiform dyskinesia and extrapyramidal symptoms associated with sertraline therapy. J Clin Psychopharmacol 1997; 17: 138-39.
18. Sarısoy S, Özyürek H, Sarısoy G. Ergen hastada sertralin kullanımıyla ilişkili oromandibular distoni. Bullet Clin Psychopharmacol 2012; 22: 83-5.
19. Stahl SM. Stahl’ın temel psikofarmakolojisi: nörobilimsel ve pratik uygulamalar. Cambridge University Press. T Uzbay (çev. ed.), 3. Baskı, İstanbul: İstanbul Medikal Yayıncılık, 2012: 535- 6.
20. Petit J. Acil psikiyatri el kitabı. Wolters Kluwer Health. M Çoşkun (çev.), İstanbul: Medikal Yayıncılık, 2006.
21. Caley CF. Extrapyramidal reactions and the selective serotoninreuptake inhibitors. Ann Pharmacother 1997; 31: 1481-9.